Leave Your Message

Akụkọ

Ịkwalite ịdị irè nke PROTAC: Ọmụmụ ihe nleba anya

Ịkwalite ịdị irè nke PROTAC: Ọmụmụ ihe nleba anya

2024-07-04

Nnyocha e mere n'oge na-adịbeghị anya na Nkwukọrịta Nature na-ekpughe nghọta ndị bụ isi n'ime ụzọ mgbama dị n'ime nke na-agbanwe ịdị irè nke mmebi protein ezubere iche site na iji PROTAC. Nchọpụta a nwere ike imeghe ụzọ maka ọgwụgwọ dị irè maka ọrịa cancer na ọrịa ndị ọzọ.

lee nkọwa
Ịkwalite ahụike na mgbake: Nlekọta kwa ụbọchị maka ndị ọrịa leukemia

Ịkwalite ahụike na mgbake: Nlekọta kwa ụbọchị maka ndị ọrịa leukemia

2024-07-03

Ịhụ na ahụmihe ọgwụgwọ dị mma ma dị ntụsara ahụ maka ndị ọrịa leukemia gụnyere nlekọta kwa ụbọchị nke ọma, gụnyere ịdị ọcha gburugburu ebe obibi, ịdị ọcha onwe onye, ​​nri na-edozi ahụ, na mmega ahụ kwesịrị ekwesị. Ntuziaka a na-enye ndụmọdụ dị mkpa maka nlekọta dị irè kwa ụbọchị iji kwado mgbake.

lee nkọwa
Usoro ọgwụgwọ cell NS7CAR-T na-egosi nkwa maka ọgwụgwọ R/R T-ALL/LBL

Usoro ọgwụgwọ cell NS7CAR-T na-egosi nkwa maka ọgwụgwọ R/R T-ALL/LBL

2024-06-20

Nnyocha e mere n'oge na-adịbeghị anya na-egosi ịdị irè na nchekwa nke ọgwụgwọ sel NS7CAR-T n'ịgwọ nlọghachi azụ ma ọ bụ refractory T-cell nnukwu lymphoblastic leukemia (R/R T-ALL) na T-cell lymphoblastic lymphoma (R/R T-LBL). Usoro ọgwụgwọ a na-enye olileanya ọhụrụ maka ndị ọrịa nwere ụdị ọrịa cancer ndị a siri ike.

lee nkọwa
Nsonaazụ mgbawa nke CD7-Ezubere iche maka CAR-T ọgwụgwọ maka T-ALL na T-LBL

Nsonaazụ mgbawa nke CD7-Ezubere iche maka CAR-T ọgwụgwọ maka T-ALL na T-LBL

2024-06-18

Nnyocha e mere n'oge na-adịbeghị anya na-akọwapụta nsonaazụ na-ekwe nkwa nke CD7-ezubere iche maka ọgwụgwọ antigen receptor (CAR) T cell n'ịgwọ ndị ọrịa nwere nnukwu lymphoblastic leukemia (T-ALL) na T-cell lymphoblastic lymphoma (T-LBL).

lee nkọwa
Mkpuchi nke Nzukọ Kwa Afọ 2024 ASH na ngosi

Mkpuchi nke Nzukọ Kwa Afọ 2024 ASH na ngosi

2024-06-13

Nzukọ Kwa Afọ nke 66 nke American Society of Hematology (ASH) ga-enwe site na December 7-10, 2024, na San Diego Convention Center, na-egosi nyocha na ọganihu dị elu na hematology.

lee nkọwa
Ịkpọsa 2024 Kwa Afọ Lu Daopei Hematology Forum na August

Ịkpọsa 2024 Kwa Afọ Lu Daopei Hematology Forum na August

2024-06-11

A ga-eme mmemme afọ iri na abụọ nke Lu Daopei Hematology na Ọgọst 23-24, 2024, na Beijing International Convention Center. Soro anyị maka mkparịta ụka nwere nghọta na ọganihu ọhụrụ na hematology.

lee nkọwa
Olileanya ọhụrụ na ọgwụgwọ ọrịa kansa: Ọgwụgwọ TIL na-apụta dị ka ihu na-esote

Olileanya ọhụrụ na ọgwụgwọ ọrịa kansa: Ọgwụgwọ TIL na-apụta dị ka ihu na-esote

2024-06-05

N'agbanyeghị ihe ịma aka na-aga n'ihu na mmepụta ihe na ịzụ ahịa, a na-edozi njedebe ọgwụgwọ CAR-T site na ụzọ ọhụrụ na-ekwe nkwa: ọgwụgwọ Tumor-Infiltrating Lymphocyte (TIL). Ọganihu a na-akpọsa oge ọhụrụ n'ọgụ megide etuto siri ike.

lee nkọwa

Usoro ọgwụgwọ cellular ọ bụ ọdịnihu nke ọrịa autoimmune?

2024-04-30

Ngwọta mgbanwe maka ọrịa cancer nwekwara ike ịgwọ ma tọgharịa usoro ahụ ji alụso ọrịa ọgụ iji nye mgbaghara ogologo oge ma ọ bụ ikekwe ọbụna gwọọ ụfọdụ ọrịa autoimmune.

lee nkọwa
2023 ASH mmeghe | Dr. Peihua Lu na-enye CAR-T maka nyochaghachi AML nke nlọghachi azụ / Refractory

2023 ASH mmeghe | Dr. Peihua Lu na-enye CAR-T maka nyochaghachi AML nke nlọghachi azụ / Refractory

2024-04-09
Ọmụmụ ihe ọmụmụ ụlọ ọgwụ nke mbụ nke CD7 CAR-T maka R/R AML site n'aka ndị otu Daopei Lu malitere na ASHEmere Nzukọ Kwa Afọ nke 65 nke American Society of Hematology (ASH) na ntanetị (San Diego, USA) na ntanetị na Disemba 9-12. , 2023. Ndị ọkà mmụta anyị mere ọmarịcha ihe ngosi nke ngalaba a...
lee nkọwa
ASH 2023|"Voice of Lu Daopei" na-abụ abụ n

ASH 2023|"Voice of Lu Daopei" na-abụ abụ n'ọgbọ mba ụwa

2024-04-09
American Society of Hematology (ASH) bụ nzukọ agụmakwụkwọ kachasị elu na ngalaba hematology n'ụwa niile. Eziokwu ahụ bụ na ahọpụtara ụlọ ọgwụ Lu Daopei dị ka onye ikpeazụ maka ASH maka afọ sochirinụ na-egosipụta n'ụzọ zuru ezu mmezu agụmakwụkwọ ya na f ...
lee nkọwa
ASH Voice nke China| Prọfesọ Xian Zhang: Ọrụ dị elu na nchekwa nke Nanobody dabere na mgbochi BCMA CAR-T ọgwụgwọ n'ịgwọ ndị ọrịa nwere nlọghachi azụ ma ọ bụ ọtụtụ Myeloma Refractory.

ASH Voice nke China| Prọfesọ Xian Zhang: Ọrụ dị elu na nchekwa nke Nanobody dabere na mgbochi BCMA CAR-T ọgwụgwọ n'ịgwọ ndị ọrịa nwere nlọghachi azụ ma ọ bụ ọtụtụ Myeloma Refractory.

2024-04-09
Emere Nzukọ Kwa Afọ nke 65 nke American Society of Hematology (ASH) site na 9 ruo 12 Disemba 2023, na San Diego, USA. Dị ka ihe omume agụmakwụkwọ kachasị elu na hematology kachasị n'ụwa, ọ na-adọta ọtụtụ puku ndị ọkachamara na ndị ọkà mmụta si n'akụkụ niile ...
lee nkọwa